A GHRH agonist studied for pulsatile pituitary growth hormone release.
TR8CE uses one simple standard: 0.1 mL of bacteriostatic water per mg. A 5 mg vial takes 0.5 mL of water for a clean 10 mg/mL solution. Larger vials scale the water up to fit the glass.
| Vial size | BAC water | Concentration | 1 mg draws to |
|---|---|---|---|
| 5 mg | 0.5 mL | 10 mg/mL | 10 units |
| 10 mg | 1 mL | 10 mg/mL | 10 units |
| 20 mg | 2 mL | 10 mg/mL | 10 units |
Units are shown for a U-100 insulin syringe. A common starting dose is 1 mg. At 10 mg/mL, that draws to 10 units on a U-100 insulin syringe.
Binds GHRH receptors on pituitary somatotroph cells to trigger a transient surge of growth hormone that mimics the body's natural pulsatile pattern.
Tesamorelin is commonly taken morning and evening.
Add 0.5 mL of bacteriostatic water to a 5 mg Tesamorelin vial for a 10 mg/mL solution.
A common Tesamorelin starting dose is 1 mg, which at 10 mg/mL draws to 10 units on a U-100 insulin syringe.
Draw bacteriostatic water into a syringe, inject it slowly down the inside glass of the Tesamorelin vial (not onto the powder), and swirl gently until clear. Store refrigerated and use within the common window.